![](https://webarchive.library.unt.edu/eot2008/20081105130623im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081105130623im_/http://www.cancer.gov/images/spacer.gif)
| A substance that is being studied in the treatment of liver cancer. It belongs to the family of drugs called thymidylate synthase inhibitors. Also called AG337 and Thymitaq. |
Previous Definitions: | node-negative, node-positive, nodular lymphocyte-predominant Hodgkin lymphoma, nodular parenchyma, nodule | Next Definitions: | Nolvadex, nomogram, non-Hodgkin lymphoma, non-small cell lung cancer, nonblinded |
|
![](https://webarchive.library.unt.edu/eot2008/20081105130623im_/http://www.cancer.gov/images/spacer.gif) |